ValiRx | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

145 results for “ValiRx”

ValiRx Secures £16 Million Licensing Deal for Repurposed Risperidone Cancer Therapy VAL401

ValiRx Expands Precision Oncology Partnership with Dominion Biotech Through PredictRx Platform Licensing

ValiRx Secures £1.16M Funding to Advance Cancer Therapeutics and Women's Health Pipeline

Valink Therapeutics Raises $11.8 Million to Advance Bispecific ADC Platform for Cancer Treatment

Valion Bio's Velocity Bioworks Secures Exclusive License for Next-Generation NMR Diagnostic Platform

RedHill Biopharma Secures U.S. Patent for Opaganib Biomarker in COVID-19 Treatment

Vienna's VALANX Biotech Secures €3 Million to Advance Precision ADC Platform for Triple-Negative Breast Cancer

Valar Labs Publishes AI Breakthrough for Pancreatic Cancer Treatment Selection in Journal of Clinical Oncology

Federal Court Dismisses Whistleblower Patent Fraud Lawsuit Against Valeant and Salix Over Ulcerative Colitis Drug Apriso